Advisors Asset Management, Inc. Bridge Bio Pharma, Inc. Transaction History
Advisors Asset Management, Inc.
- $5.23 Billion
- Q4 2024
A detailed history of Advisors Asset Management, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 9,013 shares of BBIO stock, worth $305,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,013
Previous 4,576
96.96%
Holding current value
$305,630
Previous $116,000
112.93%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$857 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$852 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$511 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$422 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$210 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.03B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...